Meet Our Board of Directors
Learn more about our Board of Directors below.
JAMES “JIM” JANICKI
Jim Janicki is a senior executive with deep experience in the medical device and life science industries where he has maximized value creation by delivering significant global healthcare improvements.
Jim has held positions running global clinical diagnostic and medical device businesses and has turned around businesses including the transformation of an 8% year over year declining revenue to 20+% revenue growth with significant operating margins improvements. He has held positions at some of the most accomplished companies in the world, including Becton Dickinson, GE, Dow Chemical, Thermo Fisher, Sun Microsystems, Life Technologies, Affymetrix, and he has experience as a corporate officer in publicly traded companies before focusing on early-stage technology companies that include initiating start-ups from their very beginning, as well as lower middle market private equity companies. Jim knows how to work at every scale of business and he has had successful exits in the past.
Jim is a registered professional engineer; he is also a certified Lean Sigma Master Black Belt efficiency expert, and has served as the Chairman of the Industrial and Professional Advisory Council for the College of Engineering at The Pennsylvania State University where he also served as the commencement speaker to the 2010 graduating class. In addition to his duties as President & CEO of Restorative Therapies Inc., he is currently the Chair of the Board for Healthcare Access Maryland, which is a $20M+ nonprofit of 220+ people in Baltimore, that is focused on providing healthcare access to the most vulnerable in society across the state of Maryland. Jim holds three patents and has a BS in Chemical Engineering from The Pennsylvania State University, an MBA from Western Michigan University, and is a graduate of the Executive Strategic Marketing program at the Stanford Graduate School of Business.
Mr. Kollender has more than 30 years of experience in the healthcare industry. He currently serves as the President and Chief Financial Officer of Strongbridge Biopharma (Nasdaq: SBBP) and previously served as a director of the Company from March 2015 until his executive-level appointment in 2019.
Since 2003, he has served first as a Principal and then Partner of Quaker Partners Management, LP, a healthcare venture capital and growth venture firm. In addition, from August 2016 through September 2018, he served as chief business officer and chief financial officer of Rapid Micro Biosystems, a Quaker Partners’ portfolio company, where he played a key role in the business expansion and adoption of the company’s Growth Direct™ System. Previously, he held positions in sales, marketing and worldwide business development at GlaxoSmithKline (GSK) and served as investment manager at its corporate venture capital arm, S.R. One. He began his career as a certified public accountant initially with KPMG.
He currently serves as chairman of the board of directors for Restorative Therapies. He also serves on the board of directors for Rapid Micro Biosystems and as an adjunct faculty member at Lehigh University. He previously served on the board of directors of Insmed, NuPathe, Inc., and Celator Pharmaceuticals, Inc, in addition to several other privately held companies. He holds an M.B.A. and a certificate degree in the graduate program in health administration and policy, both from the University of Chicago and a B.A. in accounting from Franklin and Marshall College.
Matthew joined 1315 Capital as Partner in 2017, bringing extensive healthcare investing experience across debt and equity transactions. Prior to joining 1315 Capital, he spent 9 years at HealthCare Royalty Partners, most recently as a Managing Director. He currently serves on the board of ProSciento, Restorative Therapies, and Verogen. Matthew also serves on the Board of Directors of Life Sciences Pennsylvania.
Matthew has over a decade of growth stage investing experience with a focus on the specialty pharmaceutical and medical technology sectors. Prior to HealthCare Royalty Partners, Matthew worked at Accretive LLC and Paul Capital Partners. Earlier in his career, he worked as a principal investor focused on the healthcare industry at Oak Hill Capital Partners and J.H. Whitney & Co. Matthew started his career as a healthcare investment banker at Morgan Stanley. Matthew has worked on over $1 billion in healthcare financings over the course of his career.
Matthew received a BSc in Engineering, magna cum laude, from Princeton University, an MBA with honors from The Wharton School of the University of Pennsylvania, and a Master of Biotechnology degree from the University of Pennsylvania
TINE HANSEN-TURTON, MGA, JD
Tine Hansen-Turton is President and Chief Executive Officer of Woods. Ms. Hansen-Turton is an Executive with more than 25 years of experience in health and human services senior management, executive leadership and consulting. She has founded and led several nationally recognized organizations and trade associations. A proven results-oriented strategic leader, Ms. Hansen-Turton is known for being an effective organizational change agent and policy and health and human services systems reform advocate. Woods is a $340+ million leading nonprofit population health management organization that provides innovative, comprehensive and integrated health-and-behavior, education, workforce, and care management services to children and adults in the intellectual/developmental disability, physical disability, child welfare, behavioral and acquired brain injury public health sectors. Woods has over 6000 staff that serves more than 22,000 individuals primarily from Pennsylvania, New Jersey and New York, but also has national reach given its expertise in serving people who are medically and behavioral frail and vulnerable. Ms. Hansen-Turton also oversees Woods’ four subsidiary corporations in Pennsylvania and New Jersey (Brian’s House and Tabor Services in Pennsylvania and Legacy Treatment Services, Allies and Archway Programs in New Jersey).
Ms. Hansen-Turton also serves as the founding Executive Director and Administrator for the Convenient Care Association (CCA), the national trade association of over 3000 private-sector retail clinic industry, serving 40 million people with basic health care services across the country. Ms. Hansen-Turton teaches public and social innovations, leading nonprofits, health policy and the social innovations lab at University of Pennsylvania Fels Institute of Government, Social Policy and School of Nursing.
Previously, Ms. Hansen-Turton served as the Chief Operating Officer at Public Health Management Corporation, a large public health nonprofit institute, where she oversaw and led corporate strategy, operations, business development and M&A. Additionally, she served as the founding CEO of the National Nurse-led Care Consortium, a non-profit organization supporting the growth and development of over 500 nurse-managed and school health clinics, serving more than 5 million vulnerable people across the country in urban and rural locations. For the past two decades she has also been instrumental in positioning Nurse Practitioners as primary health care providers globally.
Ms. Hansen-Turton is founder and publisher of a social impact/innovation journal (Social Innovations Journal) and have co-published nine books in the health and human services field. She is known as a serial social entrepreneur who has started several national social and public innovations in the health and human services sector.
She has received several advocacy and leadership awards, the prestigious Eisenhower Fellowship, the Business Journal 40 under 40 Leadership and Women of Distinction Awards. She was named one of the 101 emerging Philadelphia connectors by Leadership, Inc. and American Express NextGen Independent Sector Fellow.
Ms. Hansen-Turton received her BA from Slippery Rock University, her Master of Government/Public Administration from University of Pennsylvania Fels Institute and her Juris Doctor from Temple University Beasley School of Law.